MBP and multiple system atrophy: First preclinical studies in a MSA mouse model overexpressing human α-syn under the MBP promoter (line 29) demonstrated, that remyelinating molecules like the antimuscarinic benztropine are able to diminish the myelin deficit and consequently prevent neuronal cell loss in the motor cortex [12].